Primary aldosteronism—a multidimensional syndrome

AF Turcu, J Yang, A Vaidya - Nature Reviews Endocrinology, 2022 - nature.com
Primary aldosteronism is a common cause of hypertension and is a risk factor for
cardiovascular and renal morbidity and mortality, via mechanisms mediated by both …

Primary aldosteronism: molecular medicine meets public health

EAB Azizan, WM Drake, MJ Brown - Nature Reviews Nephrology, 2023 - nature.com
Primary aldosteronism is the most common single cause of hypertension and is potentially
curable when only one adrenal gland is the culprit. The importance of primary aldosteronism …

Treating primary aldosteronism-induced hypertension: novel approaches and future outlooks

N Mullen, J Curneen, PT Donlon, P Prakash… - Endocrine …, 2024 - academic.oup.com
Primary aldosteronism (PA) is the most common cause of secondary hypertension and is
associated with increased morbidity and mortality when compared with blood pressure …

Development of carbazole-based fluorescent probe for highly sensitive application in fluoride ion detection

D Li, S Tu, Y Le, Y Zhou, L Yang, Y Ding… - … Acta Part A: Molecular …, 2023 - Elsevier
Fluorine is a necessary element for human, which is closely related to life activities, such as
metabolism of teeth and bone tissue. A small amount of fluoride ions can promote the …

Multifocal, asymmetric bilateral primary aldosteronism cannot be excluded by strong adrenal vein sampling lateralization: an international retrospective cohort study

AF Turcu, Y Tezuka, JS Lim, Z Salman, K Sehgal… - …, 2024 - Am Heart Assoc
BACKGROUND: Primary aldosteronism (PA) has been broadly dichotomized into unilateral
and bilateral forms. Adrenal vein sampling (AVS) lateralization indices (LI)≥ 2 to 4 are the …

High prevalence of autonomous aldosterone production in hypertension: how to identify and treat it

T Wannachalee, L Lieberman, AF Turcu - Current Hypertension Reports, 2022 - Springer
Abstract Purpose of Review Primary aldosteronism (PA) affects millions of individuals
worldwide. When unrecognized, PA leads to cardiovascular and renal complications via …

First-in-human evaluation of [18F]CETO: a novel tracer for adrenocortical tumours

I Silins, A Sundin, M Lubberink, L O'Sullivan… - European Journal of …, 2023 - Springer
Purpose [11C] Metomidate positron emission tomography (PET) is currently used for staging
of adrenocortical carcinoma and for lateralization in primary aldosteronism (PA). Due to the …

Best practices: indications and procedural controversies of adrenal vein sampling for primary aldosteronism

KB Quencer, A Singh, A Sharma - American Journal of …, 2023 - Am Roentgen Ray Soc
Please see the Editorial Comment by Avinash Medsinge discussing this article. Please see
the Author Video associated with this article. Primary hyperaldosteronism (PA) is the most …

[HTML][HTML] Fluorinated aldosterone synthase (CYP11B2)-inhibitors for differential diagnosis between bilateral and unilateral conditions of primary aldosteronism

P Maier, B Heinze, S Gabor, S Reese, S Hahner… - Bioorganic & medicinal …, 2023 - Elsevier
The enzyme aldosterone synthase (CYP11B2) is specifically expressed in aldosterone-
producing tissue of the adrenal cortex and is overexpressed in aldosterone-producing …

A new dawn for aldosterone as a therapeutic target in hypertension

B Williams - JAMA, 2023 - jamanetwork.com
In 1953, aldosterone, then termed electrocortin, was first isolated and characterized by
James and Sylvia Tait in London. 1 A year later, Jerome Conn described the first case of …